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Darier’s disease is an autosomal dominantly inherited
skin disorder, characterized by loss of adhesion between
epidermal cells and abnormal keratinization. ATP2A2
encoding the sarcoplasmic/endoplasmic reticulum
Ca2þ ATPase (SERCA)2 has been identi¢ed as the de-
fective gene in Darier’s disease. All mutations pre-
viously reported occur in the region of ATP2A2
encoding both SERCA2a and SERCA2b isoforms.
These isoforms result from alternative splicing of exon
20, with SERCA2b being the major isoform expressed
in the epidermis. In this report, we studied a family af-
fected with Darier’s disease and identi¢ed a deletion
(2993delTG) in a region of exon 20 of ATP2A2, which
is speci¢c for SERCA2b. This heterozygous mutation
predicts a frameshift with a premature termination co-
don (PTCþ 32aa) in the eleventh transmembrane do-
main of SERCA2b. It segregates with the disease
phenotype in the family members tested, and func-
tional analysis shows a drastic reduction of the expres-
sion of the mutated protein in comparison with the
wild-type SERCA2b. Our result suggests that the mu-
tated allele causes the disease phenotype through loss
of function of SERCA2b isoform.This ¢nding indicates
that SERCA2b plays a key role in the biology of the epi-
dermis, and its defects are su⁄cient to cause Darier’s
disease. Key words: ATP2A2/SERCA2. J Invest Dermatol
121:486 ^489, 2003
D
arier’s disease (DD; OMIM 124200) is an autosomal
dominant skin disorder characterized by warty pa-
pules and plaques in the seborrheic area (central
trunk, £exures, scalp, and forehead), palmoplantar
pits, and distinctive nail abnormalities (Burge and
Wilkinson, 1992). Onset is usual before the third decade, and pe-
netrance is complete in adults, although expressivity is variable
(Munro, 1992). Mildly a¡ected patients have scattered keratotic
papules, whereas those with more severe disease present with ver-
rucous plaques or malodorous hypertrophic £exural disease. The
typical histopathology includes focal areas of separation between
suprabasal epidermal cells and abnormal keratinization. Immuno-
histopathology and electron microscopy reveal loss of desmoso-
mal attachments and perinuclear aggregates of keratin ¢laments
(Burge and Garrod, 1991).
ATP2A2, which encodes the sarcoplasmic/endoplasmic reticu-
lum Ca2þ ATPase 2 (SERCA2) pump, has been identi¢ed as the
defective gene in DD (Sakuntabhai et al, 1999a). SERCA2 belongs
to a family of P-type membrane bound ATPase, which pump
Ca2þ from the cytoplasm into reservoirs in the endoplasmic re-
ticulum (ER) lumen, using energy from ATP hydrolysis. Alter-
native splicing of exon 20 of ATP2A2 (Fig 1) produces two
isoforms, SERCA2a and SERCA2b, which di¡er only in their
C-termini (Lytton and MacLennan, 1988). SERCA2b is the major
isoform expressed in the epidermis from skin sections, although
both isoforms are detectable in cultured keratinocytes and ¢bro-
blasts (Ruiz-Perez et al, 1999).
Mutation analysis in at least 100 families with DD has shown a
variety of missense, non-sense, frameshift, and splicing mutations
in ATP2A2, and considerable interfamilial and intrafamilial phe-
notypic variability of the disease (Jacobsen et al, 1999; Ruiz-Perez
et al, 1999; Sakuntabhai et al, 1999a,b; Ringpfeil et al, 2001; Takahashi
et al, 2001;Yang et al, 2001). Recently, we have shown that somatic
mosaicism forATP2A2 causes segmental DD (Sakuntabhai et al,
2000). All these mutations occur within the ¢rst 20 exons
of ATP2A2 encoding both SERCA2 isoforms, predicting the loss
of function of both isoforms.
In this report, we studied a family a¡ected with classical DD
and identi¢ed a mutation in a region of ATP2A2 molecule,
which is speci¢c for SERCA2b.We also describe the e¡ect of this
mutation on the expression of the corresponding mutant SER-
CA2b in COS-1 cells.
MATERIALS ANDMETHODS
Clinical characteristics We studied a family of French extraction,
a¡ected with classical DD through three generations (Fig 2). The proband
is a 54 y old male who presented with severe extensive hyperkeratotic
papules and verrucous plaques of the neck, axillae, extremities, buttocks,
and perineum. He developed extended erosions of the scalp and face. He
also had oral lesion and nail involvement. The condition is exacerbated by
sunlight, heat, sweating, and has been complicated by episodes of
cutaneous herpetic and bacteria infection. Skin lesions developed when he
was 17 y old and worsen with age. He also has learning di⁄culties and
depression. He has been admitted to the hospital because of DD at least
20 times in the past 10 y. The histopathology of a skin biopsy con¢rmed
the diagnosis of DD. Treatment with oral retinoid makes his disease
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stable. Other members of the family were a¡ected with DD of varying
severity. This study was approved by the Central Oxford Committee
(C98^177).
Mutation analysis Blood samples were obtained from patients I.2, II.6,
II.11, III.8, and una¡ected individuals II.2, II.4, II.6C, II.8, and II.10 from the
family (Fig 2). Genomic DNA was extracted from peripheral blood
leukocytes using standard procedures. Polymerase chain reaction (PCR)
ampli¢cation of the 21 exons and £anking intronic splice sites of ATP2A2
from a proband (II.6) was performed using previous published primers and
conditions (Sakuntabhai et al, 1999b). ATP2A2 was screened for mutations
by conformation sensitive gel electrophoresis (CSGE), as described
(Ganguly et al, 1993). PCR products showing abnormal electrophoretic
mobility were gel puri¢ed using QIAquick PCR puri¢cation columns
(Qiagen, Crawley, UK) and sequenced directly using the ABI PRISM
AmpliTaq reaction dye terminator cycle-sequencing kit (PE Applied
Biosystems, Warrington, UK) and an Applied Biosystems model 377
automated sequencer. All products were sequenced in forward and reverse
orientations.
Construction of the ATP2A2 mutant and expression in COS-1
cells The mutation was engineered intoATP2A2 full-length SERCA 2b
cDNA cloned into the mammalian expression vector pcDNA3.1
(Invitrogen, Carlsbad CA) (kindly provided by Dr David MacLennan) by
site-directed mutagenesis using QuickChange Site-Directed Mutagenesis
Kit (Stratagene, London, UK). In order to verify that the mutation was
correct and to ensure that no unwanted mutations had occurred,
sequencing of mutant cDNA clone was performed using the previous
published cDNA primers (Sakuntabhai et al, 1999b) as described above.
The wild-type and mutant cDNA clones were transiently overexpressed
in the COS-1 cells by the calcium phosphate coprecipitation method
(Sambrook and Russell, 2001). In brief, calcium phosphate-DNA
coprecipitates were prepared by combining 100 mL of 2.5 M CaCl2 with
25 mg of plasmid DNA and bringing the volume to 1 mL with sterile
H2O. This solution was mixed with equal volume of 2HEPES-
bu¡ered saline and the calcium phosphate-DNA suspension was added to
the culture medium of COS-1 cells grown at 60% con£uency in 90 mm
dish. The transfection e⁄ciency was about 60% to 70%. Cells were
harvested at 72 h and microsomal fraction containing the overexpressed
Ca2þ ATPase was isolated as described previously (Maruyama and
MacLennan, 1988). Brie£y, cells were washed twice with phosphate-
bu¡ered saline, swollen on ice for 10 min in a hypotonic solution of 10
mM Tris^HCl and 0.5 mM MgCl2, and then homogenized in a glass
Dounce homogenizer ( Jencons, Bedfordshire, Leighton Buzzard, UK).
The suspension was centrifuged at 9000 g for 20 min to pellet nuclei
and mitochondria and supernatant was centrifuged again at 100,000 g
for 1 h to sediment the microsome fraction. Microsomes were vesicles
derived primary from the ER after cells were disrupted by
homogenization.
Immunodetection analysis To determine the localization and the
expression level of the mutant protein in comparison with wild-type
SERCA2b, immunodetection analysis, including immunocytochemistry
on intact COS-1 cells and western blotting of microsomal protein was
performed as in a standard protocol using a monoclonal anti-SERCA2
antibody (CN Biosciences, Cambridge, UK), which recognizes both
isoforms. We did not use SERCA2b antibody because this antibody
was raised against a peptide corresponding to the last 12 amino acids
(1031^1042) of the protein, which are expected to be missing in this mutant.
For immuno£uorescence analysis, 48 h after transfection, COS-1 cells
were ¢xed in methanol, and processed for indirect immuno£uorescence
and confocal microscopy. Brie£y, cells were block in 0.2% bovine serum
albumin in phosphate-bu¡ered saline containing 0.1% Triton X-100.
Bound mouse anti-SERCA2 antibody were detected using £uorescein
isothiocyanate conjugated anti-mouse secondary antibodies. Cells were
then viewed using a Nikon Optiphat Microscope and a 60 oil objective
operating on a Bio-Rad 1024 confocal system. Images were collected using
the Bio-Rad Lasersharp software for viewing (Bio-Rad Laboratories,
Hemel Hempstead Hertfordshire, UK). For western blot analysis, 10 mg of
microsomal proteins were mixed with Laemli sample bu¡er, boiled for 5
min, resolved by 7.5% sodium dodecyl sulfate^polyacrylamide gel
electrophoresis, and transferred on to PVDF membranes (Millipore,
Watford Herts, UK). Blots were probed with primary antibody, and anti-
mouse secondary antibodies linked to peroxidase (Amersham Pharmacia
Biotech, Amersham, Buckinghamshire, UK) followed by enhanced
chemiluminescent (ECL) blotting (Amersham Pharmacia Biotech).
Reverse transcription^PCR analysis Total RNA was extracted from
transfected COS-1 cells using Trizol (Invitrogen, Paisley, UK). ATP2A2
transcripts were ampli¢ed by reverse transcription^PCR using ATP2A2
speci¢c primers as previously described (Sakuntabhai et al, 1999b).
Ca2þ transport assay Ca2þ transport was measured at 371C by a rapid
Millipore ¢ltration technique as described previously (Vilsen et al, 1989).
Brie£y, Ca2þ transport activity was initiated by addition of microsomes
in a reaction mixture containing 20 mM 3-(N-Morpholino)
propanesulfonic acid (MOPS) (pH 6.8), 100 mM KCl, 5 mM MgCl2, 5
mM potassium oxalate, 5 mM ATP, 0.5 mM EGTA, 105 Bq45 Ca2þ per
mL, and 0.45 mM CaCl2 to set the free Ca
2þ concentration at 3.6 mM.
The reactions were terminated at times 5, 15, and 30 min by addition of
ice cold stop solution containing 150 mM KCl and 5 mM LaCl3 followed
by micropore ¢ltration through 0.45 mMMillipore ¢lters and an additional
washing with stop solution. The radioactivity associated with the ¢lters
was measured using a Beckman LS 6500 multipurpose scintillation
counter (Beckman, Bucks, HighWyconbe, UK).
Figure1. Splicing of ATP2A2. (A) Alternate splicing of ATP2A2 tran-
scripts at nucleotide position 2981 in exon 20 gives rise to two distinct iso-
forms, SERCA2a and SERCA2b. The mutation identi¢ed in this family
(2993delTG) is indicated (). Black boxes represent untranslated regions.
(B) Model of the human SERCA2 polypeptide. The predicted secondary
structure of SERCA2a consists of 10 transmembrane domains and a tetra-
peptide tail located in the cytoplasm, whereas the SERCA2b tail comprises
49 amino acids extending into the ER lumen.
Figure 2. Pedigree of the family. Men are represented by squares and
women by circles. The solid symbols denote the a¡ected individuals.
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RESULTS
Identi¢cation of aTG deletion in ATP2A2 CSGE analysis of
ATP2A2 ampli¢ed products from genomic DNA from proband
II.6 (Fig 3A) showed an abnormal electrophoretic mobility of
exons 19þ 20. Direct sequencing of the PCR product revealed a
TG deletion at nucleotide position 2993 (2993delTG), which
resulted in a frameshift and downstream premature termination
codon at nucleotide position 3091 (PTCþ 32aa) (Fig 3B). This
mutation is present at the heterozygous state and occurs in the
eleventh transmembrane domain of SERCA2b molecule. This
mutation was also found in the other three a¡ected individuals
tested (I2, II.11, III.8) and was absent from the una¡ected
members (I.2, II.4, II.6C, II.8, II.10) as con¢rmed by CSGE
(Fig 3A) and sequencing (data not shown). No other change
was detected in ATP2A2 by CSGE.
Expression of 2993delTG mutant Immunocytochemistry on
intact COS-1 cells (Fig 4A^C) and western blotting of 10 mg of
microsomal proteins (Fig 4D) showed that the 2993delTG
mutant was expressed at much lower level than that of the wild-
type SERCA2b. Control COS-1 cells transfected with the empty
vector showed minimal endogenous SERCA2 expression. We
tried several concentrations of DNA, di¡erent transfection
method (liposome-mediated), and subcloned cDNA into
another expression vector, pMT2, but could not increase protein
expression levels. All these experiments were repeated at least
three times. Reverse transcription^PCR analysis of COS-1 cells
transfected with the mutated cDNA showed no signi¢cant
reduction in the amount of ATP2A2 mRNA in comparison
with COS-1 cells transfected with the wild-type SERCA2b
cDNA (data not shown).
Ca2þ transport activity Oxalate-stimulated Ca2þ uptake was
measured in microsomes isolated from COS-1 cells transfected
with each of the following cDNA: wild-type SERCA2b,
2993delTG mutant cDNA, and the expression vector without any
insert.The wild-type SERCA2b showed a Ca2þ uptake rate of 5.0
nmol Ca2þ per mg microsomal protein per min. In contrast, the
mutant 2993delTG showed very low Ca2þ uptake (o0.1 nmol
Ca2þ per mg microsomal protein per min) indistinguishable
from that of microsomes isolated from COS-1 cells transfected
with the expression vector without insert (data not shown).
DISCUSSION
We have shown for the ¢rst time that DD can arise from a het-
erozygous mutation that is speci¢c for SERCA2b isoform. This
result indicates that this isoform plays an important part in epi-
dermal biology and that loss of its function is su⁄cient to cause
DD.
SERCA enzymes belong to P-type class ATPase, which form a
phosphoprotein intermediate and undergo conformation changes
during the course of ATP hydrolysis. Three known genes encode
for these SERCA pumps and di¡erential splicing of primary
transcripts gives rise to at least nine SERCA isoforms (MacLen-
nan et al, 1997; Dode et al, 1998; Martin et al, 2002). Tissue-speci¢c
alternative processing of theATP2A2 transcripts results in the ex-
pression of the cardiac and slow-twitch skeletal muscle SERCA2a
isoform and of the ubiquitous SERCA2b isoform in every other
cell type. Immunocytochemistry of adult skin sections showed
clear expression of SERCA2b in epidermal structures. Although
SERCA2a was expressed at much lower levels in the epidermis,
both isoforms were identi¢ed in cultured keratinocytes and ¢-
broblasts (Ruiz-Perez et al, 1999). SERCA2a and SERCA2b iso-
forms share a common stretch of 993 amino acids, including 10
transmembrane segments and the catalytic site. The C-terminal
of SERCA2a, however, consists of a tetrapeptide tail located in
the cytoplasm, whereas the SERCA2b tail comprises 49 residues
protruding into the ER lumen. The extended tail in SERCA2b
contains a hydrophobic stretch that is suggested to be a possible
eleventh transmembrane segment, and an asparagine residue at
position 1036 forming part of a glycosylation consensus signal
where it apparently interacts with, and is modulated by, calreticu-
lin (John et al, 1998).
The ATP2A2 mutation that we describe predicts a frameshift
with a premature termination codon in the potential eleventh
transmembrane molecule of SERCA2b. The mutation segregates
with the disease phenotype in the family. The functional analysis
of this 2993delTG SERCA2b mutant showed that the expression
level of the mutant protein was markedly reduced in comparison
with that of the wild type. This may be secondary to instability
of the truncated protein harboring an abnormal C-terminal tail
resulting in a marked reduction of Ca2þ uptake.We suggest that
in the epidermis, compensatory mechanisms by other Ca2þ
pumps are insu⁄cient to normalize Ca2þ signaling.
SERCA2þ /^ mice have revealed major di¡erences in the e¡ect
of SERCA2 dysfunction in human and mouse. These heterozy-
gous mice do not develop Darier-like lesions but display mild
impairment of cardiac contractility and relaxation due to the
reduction of SERCA2 mRNA, protein, and activity levels
Figure 3. Identi¢cation of ATP2A2 mutations. (A) CSGE showed ab-
normal electrophoretic mobility of exons 19þ 20 in a¡ected individuals;
I.2, II.6, II.11, and III.8 (lanes 1, 4, 6, 9) and normal electrophoretic mobility
in una¡ected individuals II.2, II.4, II.6C, II.8, and II.10 (lanes 2, 3, 5, 7, and 8).
Lanes 10 and 11 are from normal unrelated controls. (B) Direct sequencing
of PCR products of exons 19þ 20 revealed aTG deletion at nucleotide po-
sition 2993 (2993delTG) at a heterozygous state. This mutation resulted in a
frameshift and downstream premature termination codon at nucleotide po-
sition 3091 (PTCþ 32aa).
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(Periasamy et al, 1999; Zhao et al, 2001). The aged heterozygous
mutant mice develop squamous epithelial papillomas and carci-
nomas (Liu et al, 2001), a complication that is not reported in
DD. These observations suggest that there are species di¡erences
in susceptibility to DD and squamous cell tumors.
In conclusion, we provide the ¢rst evidence that a heterozy-
gous mutation in ATP2A2, speci¢c for the SERCA2b isoform,
is su⁄cient to cause DD. This result suggests that expression of
the normal SERCA2a isoform cannot compensate for the dys-
function of SERCA2b to maintain Ca2þ homeostasis in the epi-
dermis, emphasizing a key role of SERCA2b in skin biology.
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Figure 4. Immunodetection of the wild-type and the mutant
SERCA2b proteins. (A^C) Immuno£uorescence analysis: COS-1 cells
transfected with wild-type SERCA2b (B), the mutant 2993delTG (C), or
the empty vector (A) were processed for indirect immuno£uorescence.
Bound mouse anti-SERCA2 (A^C) was detected using £uorescein isothio-
cyanate-conjugated anti-mouse secondary antibody. (D) Western blot ana-
lysis: microsomal proteins extracted from COS-1 cells transfected with
wild-type SERCA2b, the mutant 2993delTG or the empty vector were
analyzed by western blot using mouse anti-SERCA2 antibody followed
by anti-mouse secondary antibodies linked to peroxidase, and detected by
enhanced chemiluminescent (ECL) blotting. The 212 kDa band corre-
sponds to SERCA2b dimers (Verboomen et al, 1994).
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